Skip to main content
logo
Argent BioPharma Limited (ASX:RGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0320
+0.0020 (6.67%)
Sep 4, 2026, 3:58 PM AEST

Argent BioPharma Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.160.160.180.893.394.73
Revenue Growth
-53.65%-10.73%-79.74%-73.69%-28.41%57.94%
Gross Profit
-0.04-0.04-0.6-0.31.350.56
Operating Income
-7.44-7.44-15.64-18.02-15.21-15.5
Net Income
-7.71-7.71-17.84-17.53-20.82-20.35
Earnings Per Share
-0.09-0.09-0.31-0.47-7.10-7.93
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
0.140.141.020.70.241.89
Total Debt
9.599.598.299.729.754.35
Net Cash (Debt)
-9.45-9.45-7.26-9.02-9.51-2.47
Net Cash Growth
------
Net Cash Per Share
-0.11-0.11-0.13-0.24-3.23-0.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-4.03-4.03-9.28-14.66-11.99-12.16
Capital Expenditures
-0-0-0-0.14-0.19-2.69
Free Cash Flow
-4.03-4.03-9.28-14.8-12.18-14.85
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
-24.58%-24.58%--34.13%39.88%11.89%
Operating Margin
-4617.46%-4617.46%-8663.31%-2022.52%-448.91%-327.54%
Pretax Margin
-4783.36%-4783.36%-9882.48%-1969.34%-623.80%-438.88%
Profit Margin
-4783.36%-4783.36%-9882.48%-1967.34%-614.71%-430.00%
FCF Margin
-2498.15%-2498.15%-5140.45%-1661.19%-359.40%-313.85%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
23.1524.8232.3815.244.959.23